Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.

Citi has started coverage of Gilead Sciences (NASDAQ:GILD) and Vertex Pharmaceuticals (NASDAQ:VRTX) at buy saying the former will benefit from short-term growth of Biktarvy (bictegravir, emtricitabine ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Cystic fibrosis shortened Megan Tims Phillips' life but didn't make it smaller. As her mother hoped for more time, daughter ...

As physicians we take an oath to do no harm, yet are trapped providing care in a system that leaves patients confined and at ...

EXCLUSIVE: Championed by the Daily Express, it has hailed 'amazing progress' for the 11,300 living with the genetic condition ...

Columnist Kristin Neva sometimes get overwhelmed by her increasing caregiver responsibilities, but it helps her to know she's not alone.

DelveInsight’s 'Non-Cystic Fibrosis Bronchiectasis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline non-cystic fibrosis bronchiectasis therapies in various stages of ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

Natalie Martinez produces six aces to go with eight digs in a 29-27, 25-17 win over Lemont in a Class 3A sectional final.

BX211 Phase 2 for treatment of Diabetic Foot Osteomyelitis (DFO) patient enrollment completed and on track to report topline results in Q1 ...

Sufferers now living an extra eight years on average following a Daily Express campaign to help people get lifesaving ...